Patient Resources

  1. Home
  2. Patient Resources
  3. Health Videos

Get Healthy!

GLP-1 Weight-Loss Boom Linked to Surge in Poison Control Calls

A new study found that calls to poison control centers involving popular GLP-1 weight-loss drugs climbed sharply after semaglutide was approved for obesity in 2021, with most cases linked to medication mistakes that could have been avoided.

ObesityOverweight / Underweight
HealthDay
Health News is provided as a service to Main Discount Drug Center site users by HealthDay. Main Discount Drug Center nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.

Share

Tags

ObesityOverweight / Underweight